| Literature DB >> 33440794 |
Marco Caminati1, Gabriella Guarnieri2, Gianenrico Senna1,3.
Abstract
The vaccination campaign against the Severe acute respiratory syndrome coronavirus 2 (Sars-Cov-2) started on 8 December 2020 in UK, after the approval of BNT162b2 by the Healthcare products Regulatory Agency (MHRA) [...].Entities:
Year: 2021 PMID: 33440794 PMCID: PMC7827676 DOI: 10.3390/vaccines9010038
Source DB: PubMed Journal: Vaccines (Basel) ISSN: 2076-393X